Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Matthew Collin.

Newcastle AuthorsTitleYearFull text
Professor Matthew Collin
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party2024
Professor Matthew Collin
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation2024
Dr Simon Bomken
Professor Matthew Collin
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures2024
Professor Matthew Collin
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation2024
Professor Matthew Collin
Autologous hematopoietic cell transplantation (autoHCT) for T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL): An EBMT Lymphoma Working Party study2023
Professor Matthew Collin
Histiocytes set on the heart: cardiac complications of Erdheim-Chester disease2023
Professor Matthew Collin
Histiocytic neoplasms: Going, going, but not quite gone2023
Dr Callum Wright
Dr Clare Lendrem
Dr Amy Publicover
Louise Duncan
Dr Venetia Bigley
et al.
Host versus graft HLA-DP1 mismatching promotes graft versus host disease2023
Dr Paul Milne
Dr Simon Bomken
Maymoon Madkhali
Jamie Macdonald
Dr Preeti Singh
et al.
Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis2023
Professor Matthew Collin
National advisory panels for childhood cancer in the United Kingdom: An evaluation of current practice and a best practice statement for the future2023
Professor Matthew Collin
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases2023
Professor Matthew Collin
Reading the Ts and DCs of thymopoiesis2023
Dr Alex Blain
Dr Christopher Bacon
Professor Vikki Rand
Professor Matthew Collin
Dr Christopher Carey
et al.
Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma2023
Imogen Franklin
Dr Paul Milne
Jordan Childs
Dr Roisin Boggan
Isabel Barrow
et al.
T cell differentiation drives the negative selection of pathogenic mitochondrial DNA variants2023
Professor Matthew Collin
Professor Andrew Gennery
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT2022
Dr Wei-yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al.
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)2022
Dr Ricky Tirtakusuma
Dr Katarzyna Szoltysek
Professor Vasily Grinev
Dr Sirintra Nakjang
Dr Daniel Williamson
et al.
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia2022
Professor Matthew Collin
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults2022
Dr Paul Milne
Dr Anastasia Resteu
Professor Matthew Collin
Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology2022
Professor Matthew Collin
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation2022
Dr Paul Milne
Professor Matthew Collin
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin2021
Professor Matthew Collin
FLT3 ligand in acute myeloid leukemia: a simple test with deep implications2021
Dr Preeti Singh
Maninder Heer
Dr Anastasia Resteu
Dr Aneta Mikulasova
Dr Mojgan Reza
et al.
GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS12021
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al.
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia2021
Professor Matthew Collin
Histiocytic disorders2021
Professor Matthew Collin
Histiocytosis2021
Professor Matthew Collin
Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT2021
Professor Matthew Collin
Dr Venetia Bigley
Many Langerhans make light work of skin immunity2021
Dr Paul Milne
Dr Anastasia Resteu
Professor Matthew Collin
Notch-Mediated Generation of Monocyte-Derived Langerhans Cells: Phenotype and Function2021
Dr Rachel Crossland
Jean Norden
Dr Kim Pearce
Dr Clare Lendrem
Professor Matthew Collin
et al.
Profiling Tissue and Biofluid miR-155-5p,miR-155* and miR-146a-5p Expression in Graft vs Host Disease2021
Professor Matthew Collin
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT2021
Trevor Liddle
Dr Ina Schim van der Loeff
Dr Ken Baker
Dr Christopher Duncan
Dr Aidan Hanrath
et al.
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study2020
Dr Urszula Cytlak-Chaudhuri
Dr Anastasia Resteu
Sarah Pagan
Dr Kile Green
Dr Paul Milne
et al.
Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans2020
Dr Laura Jardine
Dr Urszula Cytlak-Chaudhuri
Dr Merry Gunawan
Dr Gary Reynolds
Dr Kile Green
et al.
Donor monocyte-derived macrophages promote human acute graft-versus-host disease2020
Professor Matthew Collin
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era2020
Dr Venetia Bigley
Professor Matthew Collin
Insights from Patients with Dendritic Cell Immunodeficiency2020
Professor Matthew Collin
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease2020
Professor Matthew Collin
Kirsty Thomson
Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative2020
Dr Preeti Singh
Professor Matthew Collin
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency2020
Professor Matthew Collin
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)2019
Dr Venetia Bigley
Dr Urszula Cytlak-Chaudhuri
Professor Matthew Collin
Human dendritic cell immunodeficiencies2019
Professor Matthew Collin
Human dendritic cells2019
Dr Laura Jardine
Dr Sarah Wiscombe
Dr Gary Reynolds
Dr David McDonald
Andrew Fuller
et al.
Lipopolysaccharide inhalation recruits monocytes and dendritic cell subsets to the alveolar airspace.2019
Dr Paul Milne
Dr Venetia Bigley
Dr Amy Publicover
Sarah Pagan
Dr Helen Marr
et al.
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia2019
Professor Matthew Collin
The coming of age of Langerhans cell histiocytosis2019
Dr Katherine Sturgess
Dr Rachel Dickinson
Professor Andrew Gennery
Professor Andrew Cant
Professor Graham Jackson
et al.
In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.2018
Dr Venetia Bigley
Dr Urszula Cytlak-Chaudhuri
Dr Laura Jardine
Dr Kile Green
Dr Merry Gunawan
et al.
Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation2018
Professor Matthew Collin
Death, eaters, and dark marks2018
Sadaf Atarod
Jean Norden
Louis Bibby
Dr Clare Lendrem
Dr Kim Pearce
et al.
Differential MicroRNA Expression Levels in Cutaneous Acute Graft-versus-Host Disease2018
Professor Matthew Collin
Dr Venetia Bigley
Human dendritic cell subsets: an update2018
Dr Xiao Wang
Professor Matthew Collin
Hyaluronan Receptor LYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen2018
Dr Urszula Cytlak-Chaudhuri
Dr Anastasia Resteu
Dr Tom Altmann
Professor Andrew Gennery
Professor Graham Jackson
et al.
Ikaros family zinc finger 1 regulates dendritic cell development and function in humans2018
Dr Urszula Cytlak-Chaudhuri
Dr Anastasia Resteu
Professor Matthew Collin
Dr Venetia Bigley
Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells2018
Jean Norden
Dr Kim Pearce
Professor Julie Irving
Professor Matthew Collin
Professor Anne Dickinson
et al.
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation2018
Professor Matthew Collin
Tumour genesis syndrome in relapsed B lymphoblastic leukaemia2018
Dr Venetia Bigley
Dr Rachel Dickinson
Professor Matthew Collin
Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells2017
Professor Matthew Collin
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT2017
Dr Venetia Bigley
Professor Matthew Collin
Professor Andrew Cant
Biallelic mutations in IRF8 impair human NK cell maturation and function2017
Professor Matthew Collin
GATA2 deficiency and related myeloid neoplasms2017
Dr Paul Milne
Dr Venetia Bigley
Dr Christopher Bacon
Dr Naomi McGovern
Dr Simon Bomken
et al.
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults2017
Dr Naomi McGovern
Dr Xiao Wang
Dr Venetia Bigley
Professor Matthew Collin
Professor Muzlifah Haniffa
et al.
Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-22017
Professor Matthew Collin
I am SAMD9L: 7q regulator I am2017
Margherita Boieri
Dr Clare Lendrem
Professor Matthew Collin
Professor Anne Dickinson
IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo2017
Dr Kile Green
Dr Kim Pearce
Dr Laura Jardine
Dr Venetia Bigley
Professor Graham Jackson
et al.
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts2017
Professor Matthew Collin
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation2017
Dr Rachel Crossland
Jean Norden
Dr Kim Pearce
Dr Clare Lendrem
Louis Bibby
et al.
Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease2017
Dr Paul Milne
Dr Venetia Bigley
Professor Matthew Collin
Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA2017
Dr Venetia Bigley
Professor Matthew Collin
Dendritic cell analysis in primary immunodeficiency2016
Professor Matthew Collin
Professor Muzlifah Haniffa
Dendritic Cells and Dendritic Cell Subsets2016
Dr Tom Creasey
Dr Gail Jones
Professor Matthew Collin
Granulocyte infusion: benefit beyond neutrophils?2016
Dr Shaheda Ahmed
Dr Xiao Wang
Jean Norden
Dr Kim Pearce
Dr Ebtesam El-Gezawy
et al.
Identification and validation of biomarkers associated with acute and chronic graft versus host disease [Corrigendum]2016
Professor Matthew Collin
Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci2016
Professor Matthew Collin
Dr Paul Milne
Langerhans cell origin and regulation2016
Sadaf Atarod
Ahmed Ahmed
Dr Clare Lendrem
Dr Kim Pearce
Dr Wei Cope
et al.
MiR-146a and miR-155 expression levels in acute graft-versus-host disease incidence2016
Professor Matthew Collin
Dr Venetia Bigley
Monocyte, macrophage, and dendritic cell development: The human perspective2016
Dr Venetia Bigley
Dr Simon Bomken
Professor Matthew Collin
National Web-Based Meetings Help to Identify Histiocytosis Patients with Refractory Disease or Sequelae who Need Individualised or Novel Treatment Strategies2016
Dr Venetia Bigley
Professor Matthew Collin
Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease2016
Professor Matthew Collin
Dr Paul Milne
Dr Venetia Bigley
Professor Muzlifah Haniffa
The Hematopoietic Origin of Adult Histiocytosis2016
Professor Matthew Collin
The Mononuclear Phagocyte System in Organ Transplantation2016
Dr Sara Mannurita
Dr Venetia Bigley
Professor Matthew Collin
Dr Eleonora Gambineri
Timely follow-up of a GATA2 deficiency patient allows successful treatment2016
Dr Gary Reynolds
Dr Paul Milne
Dr Venetia Bigley
Professor Matthew Collin
Professor John Isaacs
et al.
Use of the dendritic cell marker, B and T lymphocyte attenuator, to identify functionally distinct subsets of human CD1c+ dendritic cells2016
Dr Laura Jardine
Dr Venetia Bigley
Dr Kim Pearce
Dr Alison Dickinson
Professor Graham Jackson
et al.
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants2015
Dr Jane Salotti
Dr Venetia Bigley
Dr Katrina Wood
Professor Matthew Collin
Dr Kevin Windebank
et al.
A Regional Study of Adults with Histiocytic Disorders in Northeast England2015
Professor Matthew Collin
Professor Patrick Chinnery
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy2015
Dr Venetia Bigley
Professor Matthew Collin
Autoimmune hepatitis with T-regulatory cell deficiency in the context of GATA-2 dysfunction: A novel single gene association2015
Dr Paul Milne
Dr Venetia Bigley
Dr Merry Gunawan
Professor Muzlifah Haniffa
Professor Matthew Collin
et al.
CD1c+ blood dendritic cells have Langerhans cell potential2015
Professor Matthew Collin
Dr Venetia Bigley
Cell(s) of Origin of Langerhans Cell Histiocytosis2015
Dr Lindsay Nicholson
Professor Matthew Collin
Professor Anne Dickinson
Dr Xiao Wang
Developing an in vitro predictive test for steroid response in graft versus host disease2015
Dr Lindsay Nicholson
Professor Matthew Collin
Professor Anne Dickinson
Dr Xiao Wang
Developing an in vitro predictive test for steroid response in graft versus host disease2015
Gladys -
Dr Kim Pearce
Jean Norden
Dr Clare Lendrem
Dr Rachel Crossland
et al.
Differential microRNA expressions in cutaneous acute graft-versus-host disease2015
Sadaf Atarod
Brie Turner
Dr Kim Pearce
Dr Shaheda Ahmed
Jean Norden
et al.
Elevated level of HSPA1L mRNA correlates with graft-versus-host disease2015
Professor Matthew Collin
Dr Rachel Dickinson
Dr Venetia Bigley
Haematopoietic and immune defects associated with GATA2 mutation2015
Professor Muzlifah Haniffa
Dr Venetia Bigley
Professor Matthew Collin
Human mononuclear phagocyte system reunited2015
Dr Shaheda Ahmed
Dr Xiao Wang
Jean Norden
Dr Kim Pearce
Dr Ebtesam El-Gezawy
et al.
Identification and validation of biomarkers associated with acute and chronic graft versus host disease2015
Dr Venetia Bigley
Dr Naomi McGovern
Dr Paul Milne
Dr Rachel Dickinson
Sarah Pagan
et al.
Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells2015
Dr Paul Milne
Professor Matthew Collin
Dr Venetia Bigley
Dr Christopher Bacon
Dr Naomi McGovern
et al.
Mapping the BRAFV600E Hematopoietic Clone of Adult Multi-System Langerhans Cell Histiocytosis2015
Sadaf Atarod
Dr Clare Lendrem
Dr Kim Pearce
Jean Norden
Professor Matthew Collin
et al.
MiR-146a and miR-155 expression levels in allogeneic haematopoietic stem cell transplantation patients is predictive of acute graft-versus-host incidence2015
Dr Kim Pearce
Jean Norden
Professor Matthew Collin
Professor Graham Jackson
Dr Udo Holtick
et al.
Predicting survival using clinical risk score and non-HLA immunogenetics2015
Dr Rachel Crossland
Jean Norden
Louis Bibby
Professor Matthew Collin
Professor Anne Dickinson
et al.
Serum MicroRNAs MiR-146a, MiR-199, MiR-93*and MiR-423 as Biomarkers for Graft Versus Host Disease2015
Professor Matthew Collin
Dr Paul Milne
Dr Venetia Bigley
Professor Muzlifah Haniffa
Studies on the Pathway of Differentiation of LCH Cells2015
Dr Rachel Crossland
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
Urinary MicroRNA Expression is Associated with Incidence and Severity of Graft Versus Host Disease2015
Professor Matthew Collin
Dr Laura Jardine
A question of persistence: Langerhans cells and graft-versus-host disease2014
Dr Xiao Wang
Dr Naomi McGovern
Dr Merry Gunawan
Dr Connor Richardson
Professor Matthew Collin
et al.
A Three Dimensional Atlas of Human Dermal Leukocytes, Lymphatics and Blood Vessels2014
Dr Jane Salotti
Dr Venetia Bigley
Professor Matthew Collin
An Epidemiological Survey of Adults with Histiocytic Disorders in the Northeast Region of the UK2014
Professor Matthew Collin
Dr William Howell
An Extra HLA Hapotype in Peripheral Blood: Cells Acquired from a Sibling in Utero2014
Dr Venetia Bigley
Professor Matthew Collin
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups2014
Dr Paul Milne
Dr Venetia Bigley
Dr Merry Gunawan
Professor Muzlifah Haniffa
Professor Matthew Collin
et al.
CD1c+ blood dendritic cells have Langerhans cell potential2014
Dr Xiao Wang
Dr Christopher Bacon
Alison Long
Sarah Pagan
Professor Matthew Collin
et al.
Factor XIIIa identifies macrophages and cells of mesenchymal origin in the human skin2014
Dr Naomi McGovern
Dr Merry Gunawan
Dr Laura Jardine
Dr Elizabeth Poyner
Kile Green
et al.
Human Dermal CD14+ Cells Are a Transient Population of Monocyte-Derived Macrophages2014
Dr Venetia Bigley
Dr Rachel Dickinson
Dr Laura Jardine
Dr Paul Milne
Dr Helen Griffin
et al.
Human SHP-1 Mutation Causes an Autoinflammatory and Immunodeficiency Phenotype2014
Dr Naomi McGovern
Dr Merry Gunawan
Dr Laura Jardine
Dr Elizabeth Poyner
Dr Kile Green
et al.
Human tissue mononuclear phagocyte system revisited2014
Professor Matthew Collin
Langerhans Cell Homeostasis and Turnover After Nonmyeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation2014
Dr Lucy Walker
Dr Paul Milne
Professor Matthew Collin
Lectin-like Transcript 1 in Germinal Centres2014
Dr Xiao Wang
Dr Naomi McGovern
Dr Merry Gunawan
Dr Connor Richardson
Professor Matthew Collin
et al.
Microanatomical dissection of the human dermis: the three-dimensional relationship between leucocytes, lymphatics and blood vessels2014
Professor Anne Dickinson
Professor Matthew Collin
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation2014
Dr Rachel Dickinson
Dr Paul Milne
Sarah Pagan
Dr Venetia Bigley
Professor Matthew Collin
et al.
Reduced GATA-2 expression in individuals with DCML deficiency2014
Dr Laura Jardine
Dr Kile Green
Professor Graham Jackson
Professor Matthew Collin
Synergy of Unrelated Donor and Full Intensity Conditioning Breaks the Control of Graft Versus Host Disease By Alemtuzumab2014
Professor Graham Jackson
Dr Venetia Bigley
Professor Matthew Collin
T cell depleted reduced intensity transplantation is effective for patients with GATA2 mutation and severe infections or respiratory compromise2014
Dr Rachel Dickinson
Paul Milne
Dr Laura Jardine
Dr Naomi McGovern
Dr Sharon Cookson
et al.
The evolution of cellular deficiency in GATA2 mutation2014
Dr Lindsay Nicholson
Professor Matthew Collin
Professor Anne Dickinson
Dr Xiao Wang
Treg Induced Impairment of DC Function and Its Impact on GvH Reactions2014
Dr Rachel Crossland
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease2014
Dr Kile Green
Dr Laura Jardine
Dr Kim Pearce
Dr Venetia Bigley
Professor Graham Jackson
et al.
Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study2013
Dr Kim Pearce
Dr Shaheda Ahmed
Jean Norden
Professor Matthew Collin
Dr Xiao Wang
et al.
Genomic risk factors and biomarkers as predictors of GvHD after haematopoietic stem cell transplantation2013
Professor Matthew Collin
Dr Naomi McGovern
Professor Muzlifah Haniffa
Human dendritic cell subsets2013
Dr Naomi McGovern
Dr Laura Jardine
Harriet Purvis
Professor Catharien Hilkens
Professor Matthew Collin
et al.
IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses2013
Dr Naomi McGovern
Dr Kevin Windebank
Sarah Pagan
Dr Venetia Bigley
Professor Matthew Collin
et al.
Microanatomical dissection of the human dermis: The relationship between antigen presenting cells, lymphatic and blood vessels2013
Sadaf Atarod
Dr Wei Cope
Jean Norden
Professor Matthew Collin
MiR-146a-5p and its targets in graft-versus-host disease2013
Professor Matthew Collin
Monocytes, macrophages, and dendritic cells2013
Dr Laura Jardine
Ashley Ames-Draycott
Sarah Pagan
Dr Sharon Cookson
Dr Gavin Spickett
et al.
Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment2013
Dr Laura Jardine
Professor Sophie Hambleton
Dr Venetia Bigley
Sarah Pagan
Dr Xiao Wang
et al.
Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands2013
Dr Eleonora Gambineri
Dr Sara Mannurita
Dr Venetia Bigley
Professor Matthew Collin
Timely Follow-up of a GATA2 Deficiency Patient as Predictor of Successful Treatment2013
Dr Kevin Windebank
Dr Venetia Bigley
Professor Muzlifah Haniffa
Professor Matthew Collin
Treatment of Adult LCH with Subcutaneous Cladribine2013
Dr Thomas Huegle
Dr Steven O'Reilly
Rachel Simpson
Dr Venetia Bigley
Professor Matthew Collin
et al.
Tumor Necrosis Factor-Costimulated T Lymphocytes From Patients With Systemic Sclerosis Trigger Collagen Production in Fibroblasts2013
Professor Anne Dickinson
Professor Matthew Collin
Urinary proteomic peptide profiling allows preemptive diagnosis of acute graft-versus-host-disease after allogeneic stem cell transplantation2013
Dr Emily Mavin
Sadaf Atarod
Professor Matthew Collin
Professor Anne Dickinson
Dr Xiao Wang
et al.
An association between skin homing T-cells and graft-versus-host disease2012
Dr Stamatina Verykiou
Dr Naomi McGovern
Paul Milne
Professor Matthew Collin
Professor Muzlifah Haniffa
et al.
Enhancing diagnostic sensitivity for cutaneous blastic plasmacytoid dendritic cell neoplasia2012
Professor Matthew Collin
Dr Rachel Dickinson
Professor Muzlifah Haniffa
Dr Naomi McGovern
Dr Helen Griffin
et al.
Evolution of Dendritic Cell, Monocyte B and NK Lymphoid (DCML) deficiency; a human primary immunodeficiency arising from GATA-2 mutation2012
Sadaf Atarod
Brie Turner
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
et al.
HSPA1L and HSPA1B mRNA expression in the pathogenesis of graft-versus-host disease2012
Dr Venetia Bigley
Dr Rachel Dickinson
Professor Andrew Gennery
Dr Helen Griffin
Professor Muzlifah Haniffa
et al.
Human dendritic cell deficiency2012
Professor Muzlifah Haniffa
Dr Venetia Bigley
Dr Naomi McGovern
Dr Xiao Wang
Sarah Pagan
et al.
Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells2012
Professor Muzlifah Haniffa
Dr Venetia Bigley
Dr Naomi McGovern
Dr Xiao Wang
Professor Matthew Collin
et al.
Identification of a novel cross-presenting migratory dendritic cell in the human skin: the key cell for rational vaccine strategies2012
Dr Naomi McGovern
Dr Rachel Dickinson
Dr Venetia Bigley
Professor Matthew Collin
Identification of GATA-2 mutations using a simple screening procedure in patients with Papilloma virus infections2012
Professor Muzlifah Haniffa
Dr Venetia Bigley
Dr Naomi McGovern
Dr Xiao Wang
Professor Matthew Collin
et al.
Identification of the human cross-presenting migratory dendritic cell2012
Professor Muzlifah Haniffa
Dr Venetia Bigley
Dr Naomi McGovern
Professor Matthew Collin
Identification of the human cross-presenting migratory dendritic cell and harmonization of the functional classification of human and mouse dendritic cells2012
Dr Catherine Stroud
Professor Matthew Collin
Professor Graham Jackson
Dr Terence Flood
Dr John Mansfield
et al.
Idiopathic colitis following haematopoietic stem cell transplantation for chronic granulomatous disease: Three cases at a national centre2012
Sadaf Atarod
Dr Wei Cope
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
et al.
miR-146a expression in graft-versus-host disease2012
Dr Jonathan Lane
Professor Mary Slatter
Professor Sophie Hambleton
Dr Terence Flood
Professor Andrew Cant
et al.
Outcome of haematopoietic stem cell transplantation in patients with chronic granulomatous disease at a national centre2012
Dr Katherine Sturgess
Professor Mary Slatter
Dr Venetia Bigley
Dr Rachel Dickinson
Professor Muzlifah Haniffa
et al.
Reduced-intensity haematopoietic stem cell transplant rescues immune function and corrects pulmonary alveolar proteinosis in DCML deficiency/GATA 2 mutation2012
Dr Emily Mavin
Dr Shaheda Ahmed
Dr Graeme O'Boyle
Brie Turner
Stephen Douglass
et al.
Regulatory T Cells Inhibit CD8+ T-Cell Tissue Invasion in Human Skin Graft-Versus-Host Reactions2012
Sadaf Atarod
Dr Wei Cope
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
et al.
Role of miR-146a-5p in Graft-versus-Host Disease2012
Dr Steven O'Reilly
Dr Venetia Bigley
Professor Matthew Collin
Dr Anja Krippner-Heidenreich
Professor Jaap van Laar
et al.
Tumor necrosis factor-alpha co-activated T-cells support a profibrotic cytokine milieu on cost of IL-10 expression in patients with systemic sclerosis2012
Professor Sophie Hambleton
Dr Venetia Bigley
Professor Muzlifah Haniffa
Dr Christopher Bacon
Professor Andrew Cant
et al.
IRF8 Mutations and Human Dendritic-Cell Immunodeficiency2011
Xiaomeng Wang
Brie Turner
Dr Graeme O'Boyle
Dr Saeed Ahmed
Dr Emily Mavin
et al.
Blocking effector T-cell trafficking contributes to regulatory T-cell mediated suppression of GvHD reactions2011
Professor Muzlifah Haniffa
Dr Venetia Bigley
Dr Naomi McGovern
Dr Xiao Wang
Hongwei Zhou
et al.
CD141(+) human migratory dendritic cells are homologous to murine CD103+dendritic cells and excel at exogenous antigen cross-presentation2011
Sadaf Atarod
Jean Norden
Anna Kuzyk-Czucha
Brie Turner
Lyndsy Ambler
et al.
Correlation of HSPA1Lexpression with the development of graft-versus-host disease2011
Dr Venetia Bigley
Professor Matthew Collin
Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome2011
Dr Venetia Bigley
Professor Muzlifah Haniffa
Dr Xiao Wang
Dr Rachel Dickinson
Dr Naomi McGovern
et al.
Dendritic cell, monocyte, B and NK lymphoid deficiency: a novel but potentially fatal haematological disorder curable with haematopoietic stem cell transplantation2011
Dr Kim Pearce
Jean Norden
Professor Matthew Collin
Dr Udo Holtick
Professor Anne Dickinson
et al.
Development of an algorithm to predict acute GvHD and chronic GvHD in HLA-matched sibling, non-T cell depleted haematopoietic stem cell transplants2011
Dr Rachel Dickinson
Dr Helen Griffin
Dr Venetia Bigley
Dr Louise Reynard
Raf Hussain
et al.
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency2011
Dr Samuel Moses
Professor Matthew Collin
Dr Daniela Lee
Brid Crowley
Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir2011
Dr Rachel Dickinson
Dr Venetia Bigley
Dr Helen Griffin
Professor Jeremy Lakey
Dr Naomi McGovern
et al.
Human dendritic cell deficiency is caused by GATA-2 mutation2011
Professor Matthew Collin
Dr Venetia Bigley
Professor Muzlifah Haniffa
Professor Sophie Hambleton
Human dendritic cell deficiency: the missing ID?2011
Dr Naomi McGovern
Dr Venetia Bigley
Professor Muzlifah Haniffa
Dr Xiao Wang
Dr Rachel Dickinson
et al.
Human Langerin plus dendritic cells are independent of epithelial Langerhans cells; a novel perspective on Langerhans cell histiocytosis2011
Jean Norden
Professor Matthew Collin
Professor Graham Jackson
Professor Anne Dickinson
Prognostic Significance of Interleukin-7 Receptor-alpha Gene Polymorphisms in Allogeneic Stem-Cell Transplantation: A Confirmatory Study2011
Dr Katherine Sturgess
Professor Mary Slatter
Dr Venetia Bigley
Professor Muzlifah Haniffa
Dr Xiao Wang
et al.
Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation2011
Dr Venetia Bigley
Dr Xiao Wang
Dr Rachel Dickinson
Dr Naomi McGovern
Sarah Pagan
et al.
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency2011
Dr Thomas Huegle
Dr Anja Krippner-Heidenreich
Rachel Simpson
Dr Steven O'Reilly
Dr Venetia Bigley
et al.
Tumour necrosis factor alpha receptor activated T cells of patients with systemic sclerosis are deficient in IL-10 expression but promote myofibroblast differentiation via IL-6 and TGF-beta2011
Dr Michelle Rae
Dr Xiao Wang
Professor Matthew Collin
Professor Anne Dickinson
A preliminary investigation into the kinetics of MSC induced immuno-modulation during the allo-reactive phase of an MLR2010
Dr Wei Cope
Dr Laura Jardine
Dr Venetia Bigley
Sarah Pagan
Brie Turner
et al.
A retrospective study of alemtuzumab level, t-cell chimerism and graft-versus-host disease using intermediate dose alemtuzumab for matched related and matched unrelated reduced-intensity transplantation2010
Professor Graham Jackson
Professor Matthew Collin
Jean Norden
Clinical and genetic risk assessment for overall survival in haematopoietic stem cell transplantation2010
Professor Muzlifah Haniffa
Professor Matthew Collin
Comparison of gene expression profiles between human and mouse monocyte subsets2010
Professor Muzlifah Haniffa
Professor Matthew Collin
Comparison of gene expression profiles between human and mouse monocyte subsets (Blood (2010) 115, 3 (e10-e19))2010
Dr Venetia Bigley
Dr Laura Jardine
Professor Matthew Collin
Connecting the dots: monocyte/DC and NK subsets in human peripheral blood2010
Professor Matthew Collin
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution2010
Dr Venetia Bigley
Dr Clare Morgan
Professor Matthew Collin
Dr James Lordan
Pulmonary alveolar proteinosis due to monocytopenia: lung transplant or haematopoeitic stem cell transplant? [abstract]2010
Brie Turner
Professor Matthew Collin
Reduced intensity conditioning for hematopoietic stem cell transplantation: has it achieved all it set out to?2010
Dr Rachel Dickinson
Dr Venetia Bigley
Professor Matthew Collin
The Equilibration of Peripheral Blood and Tissue CD3+T Cell Engraftment Is Influenced by Graft Versus Host Disease Following Reduced Intensity Conditioning Stem Cell Transplantation.2010
Professor Muzlifah Haniffa
Dr Venetia Bigley
Sarah Pagan
Dr Xiao Wang
Professor Matthew Collin
et al.
The persistence of recipient antigen presenting cells after stem cell transplantation in humans2010
Professor Anne Dickinson
Professor Matthew Collin
"ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation"2009
Dr Venetia Bigley
Sarah Pagan
Brie Turner
Professor Graham Jackson
Professor Anne Dickinson
et al.
A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.2009
Dr Roger Pearce
Professor Matthew Collin
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML2009
Professor Anne Dickinson
Dr Kim Pearce
Professor Graham Jackson
Professor Matthew Collin
Jean Norden
et al.
Clinical and Genetic Risk Assessment for Overall Survival in Haematopoietic Stem Cell Transplantation (HSCT)2009
Professor Muzlifah Haniffa
Dr Xiao Wang
Dr Venetia Bigley
Ian Dimmick
Dr Trevor Booth
et al.
Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation2009
Dr Laura Jardine
Professor Sophie Hambleton
Dr Venetia Bigley
Sarah Pagan
Professor Matthew Collin
et al.
Drug-Induced, NKG2D-Dependent Sensitization of ALL Cell Lines to NK Recognition2009
Professor Matthew Collin
Dr Venetia Bigley
Professor Muzlifah Haniffa
Dr Kevin Windebank
Langerin Plus Dermal Dendritic Cells: Closer to Langerhans Cell Histiocytosis than Langerhans Cells?2009
Professor Muzlifah Haniffa
Professor Matthew Collin
Mesenchymal stem cells: The fibroblasts' new clothes?2009
Brie Turner
Dr Shaheda Ahmed
Sarah Pagan
Jean Norden
Professor Matthew Collin
et al.
Regulatory T Cells Prevent Effector T Cell Infiltration Into GvHD Target Tissue by Affecting Chemokine Signaling2009
Dr Xiao Wang
Dr Udo Holtick
Professor Matthew Collin
Professor Graham Jackson
Professor Catharien Hilkens
et al.
Regulatory T-Cell Suppression of CD8+ T-Cell-Mediated Graft-Versus-Host Reaction Requires Their Presence During Priming2009
Dr Xiao Wang
Suzanne Alshemali
Professor Matthew Collin
Differential homeostasis and function of human dermal macrophages and dendritic cells: implications for the induction of graft versus host responses2008
Dr Terence Flood
Dr Gavin Spickett
Professor Graham Jackson
Professor Matthew Collin
Dr Mario Abinun
et al.
Haematopoeitic stem cell transplantation for chronic granulomatous disease - a single-centre experience2008
Professor Muzlifah Haniffa
Suzanne Alshemali
Professor Matthew Collin
Human factor XIIIa+ melanophages outlive all other cutaneous antigen-presenting cells, including Langerhans cells, after haematopoietic transplantation2008
Professor Matthew Collin
Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses2008
Professor Matthew Collin
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells2008
Dr Karen Wallace
Professor Muzlifah Haniffa
Professor Matthew Collin
Professor Matthew Wright
Skin Derived Fibroblasts Can Differentiate Into Hepatocyte-Like Cells2008
Dr Udo Holtick
Jean Norden
Professor Anne Dickinson
Professor Matthew Collin
The TLR adapter Mal/TIRAP protein variant leu 180 influences graft-versus-leukaemia and graft-versus-host reactions after allogeneic haematopoietic stem cell transplantation2008
Professor Muzlifah Haniffa
Dr Xiao Wang
Dr Udo Holtick
Dr Michelle Rae
Professor John Isaacs
et al.
Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells2007
Professor Andrew Gennery
Professor Matthew Collin
Follow up in the first year after hemopoietic stem cell transplantation2007
Dr Udo Holtick
Dr Scott Marshall
Professor Stephen O'Brien
Professor Matthew Collin
Potent graft-versus-leukemia effect in BCR/ABL negative chronic myelogenous leukemia2007
Dr Udo Holtick
Professor Anne Dickinson
Dr Peter Middleton
Professor Matthew Collin
Impact of mismatching CD1a, a dimorphic antigen-presenting molecule, on graft-versus-host disease after hematopoietic stem cell transplantation2006
Dr Scott Marshall
Professor Matthew Collin
Professor Anne Dickinson
Phase II prospective study of extracorporeal phototherapy for the treatment of refractory chronic extensive graft-versus-host disease performed in Newcastle Upon Tyne2006
Dr Xiao Wang
Professor Matthew Collin
Professor Graham Jackson
Professor Anne Dickinson
Skin Explant Model of Human Graft-Versus-Host Disease: Prediction of Clinical Outcome and Correlation with Biological Risk Factors2006
Professor Matthew Collin
Professor Graham Jackson
Dr Jennifer Cavet
Dr Peter Middleton
Professor Anne Dickinson
et al.
The fate of human Langerhans cells in hematopoietic stem cell transplantation2006
Dr Udo Holtick
Dr Peter Middleton
Jane Harrold
Professor Anne Dickinson
Professor Matthew Collin
et al.
The MyD88 adapter-like (Mal) protein variant Leu 180, a candidate polymorphism for protection against graft versus host disease2006
Professor Matthew Collin
Dr Xiao Wang
Professor Anne Dickinson
In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: Implications for the control of graft-versus-host disease2005
Professor Matthew Collin
Dr Trevor Booth
Professor Anne Dickinson
The effect of conditioning therapy on Langerhans' cell density in human bone marrow transplantation2004
Professor Matthew Collin
Dr Xiao Wang
Professor Anne Dickinson
Antibody-mediated suppression of allogeneic responses by targeting the tissue dendritic cell: A potential role for CMRF-44 where alemtuzumab fails2003
Dr Richard Bellamy
Professor Matthew Collin
David Wilkinson
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan2000
Professor Matthew Collin
Drug interactions, renal impairment and hypoglycaemia in a patient with Type II diabetes1999